VIM and ovarian serous cystadenocarcinoma: In line with these data, we found that L1CAM, vimentin and TGF-β1 are co-regulated in ovarian serous cystadenocarcinoma, and high expression of this gene signature is associated with reduced overall survival in a cohort of patients with ovarian serous cystadenocarcinoma.